Oleg Moskvin, PhD ,is a computational biologist who brings together experiences and mindsets from network-centric *omics data analysis in both prokaryotic and eukaryotic systems, genome analysis, classical biochemistry and machine learning. His research career involved the discovery of novel functionality in bacterial genomes, and extensive *omics studies related to areas ranging from biofuel research and bacteria-environment interactions to stem cell differentiation, supplemented with the development of related computational approaches. The number of publications that cite Dr. Moskvin’s work exceeds 3,200.
In 2018-2022, as Group Lead of Wilmar International R&D, he applied his expertise to establish and conducting, data analysis and follow-up human studies of the gut microbiome component of dietary intervention clinical trials, including function-centric metagenome analysis, development of a cutting-edge custom protocol for long-read metatranscriptomics, as well as whole-genome metabolic modeling of key bacterial species and follow-up in vitro studies.
Dr. Moskvin’s multifaceted vision of the computational life sciences now positions him to lead key BluMaiden Biosciences initatives, ranging from in-house *omics data analysis and AI predictive modeling of clinical phenotypes to an inter-domain translation engine connecting the world of genomic “dark matter” with the world of small molecules.